首页> 外文会议>American College of Veterinary SurgeonsACVS Surgery Summit >MINIMALLY INVASIVE OSTEOSYNTHESIS THE GOOD / THE BAD / THE UGLY
【24h】

MINIMALLY INVASIVE OSTEOSYNTHESIS THE GOOD / THE BAD / THE UGLY

机译:微创骨质合成良好/坏/丑陋

获取原文

摘要

Biological osteosynthesis principles, particularly for the treatment of diaphyseal fractures, are readily implemented in human orthopaedics and are gaining momentum and acceptance in veterinary medicine. The impetus behind the development of minimallyinvasive osteosynthesis (MIO) principles and techniques was in large part due to the recognition and identification of the shortcomings of open reduction and internal fixation (ORIF) with anatomical reconstruction and rigid fixation using conventional plating. As with any evolutionary step in medicine however, critical evaluation of a new standard of care inevitably leads to the documentation of different boundaries intrinsic to this novel approach. Our incentive to continue to progress is the hope that these new limits will be associated with lower morbidity, better functional outcomes and complications easier to manage when they do occur.
机译:生物骨质合成原理,特别是用于治疗透析性骨折,易于在人骨科中实施,并在兽医中获得势头和接受。由于识别和鉴定了使用常规电镀的解剖学重建和刚性固定的开放性和内固定(ORIF)的识别和鉴定,因此大部分侵蚀性骨质合成(MIO)原理和技术的推动力大部分是大部分。与医学中的任何进化步骤一样,对新的护理标准的批判性评估不可避免地导致不同界限的文件内在这种新方法。我们的激励继续进步是希望这些新限制与较低的发病率相关,更好的功能结果和并发症更容易管理它们。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号